|
US4925572A
(en)
*
|
1987-10-20 |
1990-05-15 |
Pall Corporation |
Device and method for depletion of the leukocyte content of blood and blood components
|
|
US4880548A
(en)
*
|
1988-02-17 |
1989-11-14 |
Pall Corporation |
Device and method for separating leucocytes from platelet concentrate
|
|
DE68921918T2
(de)
*
|
1988-05-09 |
1995-09-07 |
Univ Temple |
Verfahren zur Voraussage der Wirksamkeit einer antineoplastichen Behandlung bei einzelnen Patienten.
|
|
US5210015A
(en)
*
|
1990-08-06 |
1993-05-11 |
Hoffman-La Roche Inc. |
Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
|
|
US5474909A
(en)
*
|
1992-08-07 |
1995-12-12 |
Anticancer, Inc. |
Noncolorimetric histoculture method for predicting drug response of tumors
|
|
US7625697B2
(en)
*
|
1994-06-17 |
2009-12-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for constructing subarrays and subarrays made thereby
|
|
US5491063A
(en)
*
|
1994-09-01 |
1996-02-13 |
Hoffmann-La Roche Inc. |
Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
|
|
DE69739909D1
(de)
*
|
1996-03-26 |
2010-07-29 |
Michael S Kopreski |
Methoden aus plasma oder serum extrahierte extrazelluraere rna zur diagnoseüberwachung oder evaluation von krebs verwenden
|
|
US5683698A
(en)
|
1996-08-02 |
1997-11-04 |
New England Deaconess Hospital |
Formulation for alleviating symptoms associated with arthritis
|
|
US7514232B2
(en)
*
|
1996-12-06 |
2009-04-07 |
Becton, Dickinson And Company |
Method for detecting T cell response to specific antigens in whole blood
|
|
US20020006613A1
(en)
*
|
1998-01-20 |
2002-01-17 |
Shyjan Andrew W. |
Methods and compositions for the identification and assessment of cancer therapies
|
|
AU768189B2
(en)
*
|
1999-06-15 |
2003-12-04 |
Nutri-Logics, Inc. |
Nutrient formulations for disease reduction, and related treatment and component screening methods
|
|
US6692916B2
(en)
*
|
1999-06-28 |
2004-02-17 |
Source Precision Medicine, Inc. |
Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
|
|
US20020048566A1
(en)
*
|
2000-09-14 |
2002-04-25 |
El-Deiry Wafik S. |
Modulation of cellular apoptosis and methods for treating cancer
|
|
ATE480618T1
(de)
*
|
2000-10-31 |
2010-09-15 |
Hitachi Chemical Res Ct Inc |
Methode für das sammeln und das verwenden von kern-mrna
|
|
US20020182274A1
(en)
|
2001-03-21 |
2002-12-05 |
Kung-Ming Lu |
Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
|
|
US7767390B2
(en)
*
|
2001-11-20 |
2010-08-03 |
Oncomedx, Inc. |
Methods for evaluating drug-resistance gene expression in the cancer patient
|
|
FI20020078A7
(fi)
*
|
2002-01-15 |
2003-07-16 |
Danisco |
Immuunijärjestelmän stimulointi polydextroosilla
|
|
US6878518B2
(en)
*
|
2002-01-22 |
2005-04-12 |
The Trustees Of The University Of Pennsylvania |
Methods for determining steroid responsiveness
|
|
JP2005525114A
(ja)
*
|
2002-04-24 |
2005-08-25 |
ヒタチ ケミカル リサーチ センター インコーポレイテッド |
全血からのｍＲＮＡをハイスループットに定量するための装置および方法
|
|
US7745180B2
(en)
*
|
2002-04-24 |
2010-06-29 |
Hitachi Chemical Co., Ltd. |
Device and method for high-throughput quantification of mRNA from whole blood
|
|
WO2004012755A1
(en)
*
|
2002-08-05 |
2004-02-12 |
The Wistar Institute |
Methods for regulating brca1-brca2-containing complex activity
|
|
GB0219642D0
(en)
*
|
2002-08-23 |
2002-10-02 |
Gauthier Pierre |
Method and device for preparing tissues sections
|
|
AU2002953533A0
(en)
*
|
2002-12-24 |
2003-01-16 |
Arthron Limited |
Fc receptor modulating compounds and compositions
|
|
JP2008503206A
(ja)
*
|
2004-05-25 |
2008-02-07 |
日立化成工業株式会社 |
癌感受性を測定する方法
|
|
JP4800384B2
(ja)
*
|
2005-06-08 |
2011-10-26 |
ヒタチ ケミカル リサーチ センター インコーポレイテッド |
腫瘍細胞及び刺激された白血球におけるｍＲＮＡの発現プロファイルに基づく腫瘍性疾患に対する免疫応答を予測する方法
|
|
EP1945814A2
(en)
*
|
2005-09-27 |
2008-07-23 |
Source MDX |
Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
|
|
ATE518011T1
(de)
*
|
2006-04-07 |
2011-08-15 |
Hitachi Chemical Co Ltd |
Erhöhte expression von t- zellenrezeptorvermittelter tumornekrosefaktorsuperfamilie und chemokin-mrna in peripheren blut leukozyten bei patienten mit morbus& xa;crohn
|
|
JP2009536021A
(ja)
*
|
2006-04-07 |
2009-10-08 |
日立化成工業株式会社 |
関節リウマチの患者の末梢血白血球におけるＦＣ受容体媒介性腫瘍壊死因子スーパーファミリ及びケモカインのｍＲＮＡ発現の増大
|
|
US20090298071A1
(en)
*
|
2006-05-08 |
2009-12-03 |
Masato Mitsuhashi |
Method for testing drug sensitivity in solid tumors by quantifying mrna expression in thinly-sliced tumor tissue
|
|
JP2011502535A
(ja)
*
|
2007-11-14 |
2011-01-27 |
日立化成工業株式会社 |
末梢血白血球における、Ｆｃ受容体を介した腫瘍壊死因子スーパーファミリーｍＲＮＡ発現
|
|
US20090215064A1
(en)
*
|
2008-02-27 |
2009-08-27 |
Hitachi Chemical Co., Ltd. |
Quantitative assessment of individual cancer susceptibility by measuring dna damage-induced mrna in whole blood
|